Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-myc | 6 | 2019 | 126 | 1.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 1284 | 1.060 |
Why?
|
| Carcinoma, Papillary, Follicular | 1 | 2020 | 14 | 0.730 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2022 | 132 | 0.690 |
Why?
|
| ras Proteins | 1 | 2020 | 130 | 0.680 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 147 | 0.670 |
Why?
|
| Ribosomal Proteins | 2 | 2018 | 45 | 0.630 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 264 | 0.630 |
Why?
|
| Liver Neoplasms | 3 | 2017 | 755 | 0.530 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 426 | 0.520 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 1098 | 0.500 |
Why?
|
| Transcriptome | 1 | 2020 | 661 | 0.500 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 269 | 0.500 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 1185 | 0.500 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 1061 | 0.470 |
Why?
|
| Up-Regulation | 1 | 2017 | 726 | 0.470 |
Why?
|
| Neoplasms | 5 | 2024 | 3067 | 0.440 |
Why?
|
| Liver | 2 | 2017 | 1211 | 0.420 |
Why?
|
| Genome, Human | 1 | 2018 | 791 | 0.420 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 399 | 0.420 |
Why?
|
| Hepatocytes | 3 | 2018 | 122 | 0.410 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 1131 | 0.340 |
Why?
|
| Prognosis | 1 | 2018 | 3800 | 0.340 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2024 | 1255 | 0.340 |
Why?
|
| Gene Expression Profiling | 7 | 2021 | 1452 | 0.340 |
Why?
|
| Hepatoblastoma | 3 | 2018 | 12 | 0.330 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2019 | 26 | 0.320 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 2370 | 0.270 |
Why?
|
| Computers | 1 | 2024 | 111 | 0.230 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1670 | 0.210 |
Why?
|
| Mouth Diseases | 1 | 2023 | 16 | 0.210 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2022 | 6 | 0.210 |
Why?
|
| Uncertainty | 1 | 2022 | 76 | 0.200 |
Why?
|
| Medicine | 1 | 2022 | 91 | 0.190 |
Why?
|
| Precancerous Conditions | 1 | 2023 | 201 | 0.190 |
Why?
|
| Induction Chemotherapy | 1 | 2022 | 152 | 0.180 |
Why?
|
| Papillomaviridae | 1 | 2022 | 156 | 0.180 |
Why?
|
| Humans | 15 | 2024 | 89985 | 0.180 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 199 | 0.180 |
Why?
|
| Specimen Handling | 1 | 2021 | 103 | 0.180 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 376 | 0.180 |
Why?
|
| Glycolysis | 2 | 2019 | 135 | 0.180 |
Why?
|
| Software | 1 | 2024 | 669 | 0.170 |
Why?
|
| Mitochondrial Proteins | 2 | 2017 | 127 | 0.170 |
Why?
|
| Genomics | 1 | 2024 | 778 | 0.160 |
Why?
|
| Lipid Metabolism | 2 | 2018 | 201 | 0.160 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 21 | 0.150 |
Why?
|
| Mitochondrial Turnover | 1 | 2017 | 1 | 0.140 |
Why?
|
| Electron Transport Complex II | 1 | 2017 | 3 | 0.140 |
Why?
|
| Electron Transport Complex I | 1 | 2017 | 31 | 0.140 |
Why?
|
| Ribosomes | 1 | 2017 | 116 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2017 | 178 | 0.130 |
Why?
|
| Liver Regeneration | 1 | 2016 | 36 | 0.130 |
Why?
|
| Proteomics | 1 | 2018 | 232 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2017 | 310 | 0.130 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 13 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 855 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2017 | 216 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2018 | 2016 | 0.120 |
Why?
|
| Mitochondria | 2 | 2016 | 556 | 0.120 |
Why?
|
| DNA Repair | 1 | 2017 | 363 | 0.120 |
Why?
|
| Pyruvate Dehydrogenase Complex | 3 | 2019 | 13 | 0.120 |
Why?
|
| Mutation | 3 | 2021 | 4169 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 490 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 3 | 2019 | 55 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 728 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1579 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1545 | 0.110 |
Why?
|
| Animals | 8 | 2019 | 27536 | 0.100 |
Why?
|
| B7-H1 Antigen | 2 | 2023 | 279 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 1355 | 0.090 |
Why?
|
| Machine Learning | 2 | 2023 | 270 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2018 | 1665 | 0.090 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 332 | 0.080 |
Why?
|
| Acetyl Coenzyme A | 2 | 2017 | 9 | 0.070 |
Why?
|
| Fatty Acids | 2 | 2018 | 134 | 0.070 |
Why?
|
| Mice | 5 | 2019 | 11858 | 0.070 |
Why?
|
| Biomarkers | 2 | 2023 | 1778 | 0.070 |
Why?
|
| Algorithms | 2 | 2024 | 1913 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2023 | 4329 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1158 | 0.060 |
Why?
|
| European Union | 1 | 2023 | 8 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2018 | 2026 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2887 | 0.050 |
Why?
|
| Data Accuracy | 1 | 2021 | 32 | 0.050 |
Why?
|
| Computational Biology | 1 | 2024 | 551 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 841 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 528 | 0.040 |
Why?
|
| Survival Rate | 1 | 2024 | 1899 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3253 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 476 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 53 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 119 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 12 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2023 | 699 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2017 | 272 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 104 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 194 | 0.030 |
Why?
|
| Female | 2 | 2017 | 46602 | 0.030 |
Why?
|
| Cell Size | 1 | 2016 | 69 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1292 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 2000 | 0.030 |
Why?
|
| Triglycerides | 1 | 2016 | 233 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 316 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 154 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2016 | 282 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 1682 | 0.030 |
Why?
|
| Proteome | 1 | 2015 | 135 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 388 | 0.030 |
Why?
|
| Male | 1 | 2017 | 42690 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1497 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2327 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2588 | 0.030 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2016 | 175 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 9216 | 0.020 |
Why?
|